Background/Introduction: The use of oral and intravenous corticosteroids as a treatment for
SARS-CoV-2 infection has been shown to inhibit the exaggerated inflammatory response …

Objective: To assess the safety profile of corticosteroids treatment, at high and low doses, in
suspected or confirmed patients with COVID-19, determining the most frequent side effects …

Severe infection of COVID-19 is characterized by an excessive inflammatory response in a
form of a storm of proinflammatory cytokines leading to severe lung injury and life …

Corticosteroids use in severe and critical COVID-19 patients is recommended by
international guidelines, as they reduce mortality. However, the use outside of these …

The current evidence suggests that the rapid clinical progression of the Coronavirus
Disease 2019 (COVID-19) pandemic, caused by the Severe Acute Respiratory Syndrome …

Corticosteroids (also called glucocorticoids or steroids) are antiinflammatory drugs. They are
used to treat a wide range of conditions, including asthma, eczema and certain types of …

Corticosteroids have received increasing focus as an emerging therapy in COVID-19,
particularly in patients receiving respiratory support as demonstrated by the RECOVERY …

The aim of this study was to evaluate the clinical effects of dexamethasone administration in
patients with mild to moderate acute respiratory distress syndrome (ARDS) due to …

Objective To assess the efficacy of corticosteroids in patients with coronavirus disease 2019
(COVID-19). Methods A multicentre observational study was performed from 22 February …

Background/Introduction: Hyperglycemia has been identified as an independent predictor of
mortality in hospitalized patients with COVID-19. Administration of systemic corticosteroids …